- Home
- GSK vs EQNR Comparison
GSK vs EQNR Comparison
Compare GSK & EQNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSK | EQNR |
|---|---|---|
| Founded | 1715 | 1972 |
| Country | United Kingdom | Norway |
| Employees | 66841 | 24140 |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.1B | 91.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GSK | EQNR |
|---|---|---|
| Price | $54.35 | $37.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | N/A | ★ $37.00 |
| AVG Volume (30 Days) | 3.6M | ★ 6.7M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | 3.14% | ★ 3.19% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.99 | $13.35 |
| Revenue Next Year | $4.19 | N/A |
| P/E Ratio | $32.75 | ★ $14.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.45 | $21.96 |
| 52 Week High | $61.70 | $43.46 |
Technical Indicators
Market Signals| Indicator | GSK | EQNR |
|---|---|---|
| Relative Strength Index (RSI) | 40.88 | 50.30 |
| Support Level | $47.89 | $23.15 |
| Resistance Level | $59.97 | $42.76 |
| Average True Range (ATR) | 0.99 | 1.23 |
| MACD | -0.35 | -0.44 |
| Stochastic Oscillator | 3.62 | 40.29 |
Price Performance
Historical ComparisonAbout GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About EQNR Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2024 (52% liquids) and ended 2024 with 6.1 billion barrels of proven reserves (42% liquids). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.